{"schema_version":"secwatch.filing_event.v1","accession":"0000899923-24-000065","form_type":"8-K","ticker":"MYGN","cik":"0000899923","company_name":"MYRIAD GENETICS INC","filed_at":"2024-12-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.331090+00:00","generated_at":"2026-05-29T05:25:50.450231+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Myriad Genetics appoints Mark S. Davis to Board, expanding to nine members","bullets":["Mark S. Davis appointed as Class I Director effective December 10, 2024, expanding Board from eight to nine.","Davis will serve on Audit and Finance Committee; deemed independent and an audit committee financial expert.","Received restricted stock unit award of $350,000 vesting one year from grant date.","Davis spent nearly 40 years at Deloitte & Touche LLP, last as National Managing Partner of Deloitte Private.","Also serves on boards of Yext, Inc., NYU-Winthrop Hospital, and Adelphi University."],"urls":{"canonical":"https://secwatch.observer/filing/0000899923-24-000065","json":"https://secwatch.observer/filing/0000899923-24-000065.json","markdown":"https://secwatch.observer/filing/0000899923-24-000065.md","text":"https://secwatch.observer/filing/0000899923-24-000065.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/899923/000089992324000065/0000899923-24-000065-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/899923/000089992324000065/mygn-20241210.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T05:25:50.450231+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}